Skip to main content

$0.040 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
4 July 2025 at 11:16am
Register to track AC8 and receive email alerts.

AusCann Completes Successful Meeting with the U.S. FDA

StockBot

416,823 posts

AC8 released this announcement to the ASX on 9 December 2021, 10:12. The announcement is marked as price sensitive, and is 2 page(s) in length and 171.6kb in size.

You can view all announcements from AC8 and see how they appear on a price chart on the announcements page.

At the date of this announcement, AC8 was 0.053% short sold according to ASIC data. It was ranked the 520th most shorted stock on the ASX. It remains ranked 619th as of the latest reported data (21 February 2022).

Other Recent Announcements from AC8
Final Director's Interest Notice - C. Mews 29 June 2023, 9:44
Initial Director's Interest Notice - B. Mitchell 29 June 2023, 9:44
Appointment of Independent Non-Executive Director 29 June 2023, 9:19
AusCann Completes Successful Meeting with the U.S. FDA 9 December 2021, 10:12
Final Director's Interest Notice x 2 16 November 2021, 9:09
AusCann Board Changes 16 November 2021, 8:19
Results of Annual General Meeting 15 November 2021, 17:18
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track AC8 and receive email alerts.